Adelphi Real World provide global in-depth understanding of the dynamics in distinct disease and decision areas to address customised strategic marketing, business intelligence, health outcomes, value and communication issues across the brand lifecycle.

Disease understanding and expertise are critical in ever more challenging therapeutic areas. Research conducted in Real World settings is essential in providing unbiased information on factual behaviour.

Holistic benchmarks of disease are a pre-requisite to define and assess independently the real dynamics of the disease as well as opportunities and the impact of medico-marketing strategies.

Unmet therapeutic needs can be defined and monitored through a thorough evaluation of clinical practice, doctor evaluations and perceptions, patient feedback, motivation, level of knowledge and satisfaction.

Market definitions, brand performance and potential rely on precise, measurable and disease-specific indicators, collected in a Real World setting.

Disease Specific Programmes

Our Disease Specific Programmes ( DSP®) provide an integrated approach combining doctor and patient outputs incorporating payor and carer perspectives.

Based individually on up to 12,000 patients and 1,000 doctors worldwide and repeated at regular intervals, each DSP constitutes a ‘gold standard’ reference in the industry in challenging therapeutic areas including: metabolic, autoimmune, respiratory, cardiovascular, CNS, pain and oncology.

Observational Research

Our Bespoke Observational Research capabilities capitalise on our extensive experience across disease areas and geographical markets worldwide.

We provide full-service design, implementation and delivery of global observational studies (retrospective, cross-sectional, longitudinal) pertaining to disease understanding, burden and resource utilisation as well as the efficacy and optimal use of products.

Combined with our communications expertise, this allows our clients to target a wide range of audiences including doctors and registration authorities as well as reimbursement and pricing organisations.

Corporate Image Research

Our NHS Company image study has been available in Primary Care annually since 1995.  It captures both current views and changes over time in the perceptions of pharmaceutical company interactions with the NHS. 

In 2009, we are launching the NHS Oncology Company Image study and the NHS Mental Health Company Image study.

Click here for details of all DSP's

Click here for details of what each DSP provides

Click here for DSP cutcomes solutions

Click here for DSP communications solutions